- Home
- BEAT vs HBIO Comparison
BEAT vs HBIO Comparison
Compare BEAT & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- HBIO
- Stock Information
- Founded
- BEAT 2015
- HBIO 1901
- Country
- BEAT United States
- HBIO United States
- Employees
- BEAT N/A
- HBIO N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- BEAT Technology
- HBIO Industrials
- Exchange
- BEAT Nasdaq
- HBIO Nasdaq
- Market Cap
- BEAT 65.1M
- HBIO 61.2M
- IPO Year
- BEAT 2021
- HBIO 2000
- Fundamental
- Price
- BEAT $2.08
- HBIO $0.99
- Analyst Decision
- BEAT Buy
- HBIO
- Analyst Count
- BEAT 1
- HBIO 0
- Target Price
- BEAT $8.00
- HBIO N/A
- AVG Volume (30 Days)
- BEAT 131.3K
- HBIO 277.2K
- Earning Date
- BEAT 03-19-2025
- HBIO 03-06-2025
- Dividend Yield
- BEAT N/A
- HBIO N/A
- EPS Growth
- BEAT N/A
- HBIO N/A
- EPS
- BEAT N/A
- HBIO N/A
- Revenue
- BEAT N/A
- HBIO $97,732,000.00
- Revenue This Year
- BEAT N/A
- HBIO N/A
- Revenue Next Year
- BEAT N/A
- HBIO $4.32
- P/E Ratio
- BEAT N/A
- HBIO N/A
- Revenue Growth
- BEAT N/A
- HBIO N/A
- 52 Week Low
- BEAT $1.35
- HBIO $0.94
- 52 Week High
- BEAT $3.48
- HBIO $4.70
- Technical
- Relative Strength Index (RSI)
- BEAT 39.34
- HBIO 16.00
- Support Level
- BEAT $2.05
- HBIO $1.26
- Resistance Level
- BEAT $2.37
- HBIO $1.43
- Average True Range (ATR)
- BEAT 0.18
- HBIO 0.10
- MACD
- BEAT -0.02
- HBIO -0.03
- Stochastic Oscillator
- BEAT 21.24
- HBIO 6.05
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.